To evaluate sensitivity to bendamustine, primary cells from 38 untreated CLL cases were incubated with the drug at the physiological dose of 25 μM and cytotoxicity was determined after 24 hours by double staining with Annexin-V/propidium iodide (PI). This evidence concerns the gene ANXA5 and B-cell chronic lymphocytic leukemia.